Scale and capacity Resonetics operates a global network of 20 manufacturing facilities with ISO 13485:2016 certification, enabling rapid scale from prototype to high-volume production across multiple medical device segments. This presents a sales opportunity to customers seeking a single integrated partner to manage expansion and supply chain security as demand grows.

Integrated capability The company offers end-to-end capabilities including laser processing, nitinol fabrication, metal fabrication, and raw material supply, plus full product integration from raw material to finished assembly. This enables cross-sell of design-to-manufacturing services to startups and established device companies aiming to consolidate suppliers.

Strategic acquisitions Resonetics has recently pursued and completed strategic acquisitions, including Resolution Medical, signaling a push to broaden design and manufacturing solutions and enter new market adjacencies. This suggests opportunity for joint ventures or collaboration on larger, complex devices requiring broader CDMO capabilities.

Emerging markets Expansion plans for Costa Rica with a third manufacturing plant and 300 new jobs indicate aggressive geographic growth and supply chain diversification. This creates opportunities to offer regionalized manufacturing solutions, local service continuity, and faster time-to-market for customers with regional demand.

Energy and neuromodulation focus Recent integrations with energy-related implantable technologies and neuromodulation platforms position Resonetics to address customers in BCI, CRM, and neurostimulation markets. Sales conversations can emphasize end-to-end energy source to device assembly capabilities for these high-value, technically demanding applications.